Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cheng Liu currently holds 900,000 shares of Estrella Immunopharma, Inc. (ESLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cheng Liu has been a net neutral trader of ESLA stock. They have purchased $0 and sold $0 worth of shares.
Cheng Liu's most recent insider trade was on Aug 25, 2026, when they sold 100,000 shares at $0.00 per share.
Cheng Liu serves as Executive at Estrella Immunopharma, Inc. (ESLA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Cheng Liu holds the position of Executive at Estrella Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Cheng Liu has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cheng Liu was on Aug 25, 2026, when they sold $81.5K worth of ESLA shares. This transaction involved 100,000 shares at $0.82 per share.
Cheng Liu currently owns 900,000 shares of Estrella Immunopharma, Inc. (ESLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cheng Liu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cheng Liu has 2 Form 4 filings on record as an insider at Estrella Immunopharma, Inc..
Set alerts for Cheng Liu and 40,000+ other insiders.